A California doctor has been convicted in a massive Medicare fraud scheme involving nearly $45 million in fraudulent Botox claims, in what federal prosecutors called the largest Botox fraud scheme ever prosecuted in the United States.
According to the US Department of Justice, Dr. Violetta Mailyan was found guilty by a federal jury on multiple charges linked to a years-long healthcare fraud operation that allegedly targeted elderly Medicare patients through medically unnecessary Botox treatments and false billing practices.
The investigation began after the DOJ’s Health Care Fraud Section Data Analytics Team identified Dr. Mailyan as an unusually high Medicare Botox biller nationwide.
The DOJ stated that Dr. Mailyan, a 45-year-old neurologist based in Glendale, California, owned and operated Healthy Way Medical Center, a clinic that promoted cosmetic and beauty services while allegedly participating in the fraudulent billing scheme over several years.
Prosecutors said the scheme generated millions of dollars in improper Medicare reimbursements while exposing patients to medically unnecessary Botox treatments. Authorities said Dr. Mailyan was convicted of nine counts of wire fraud and three counts of obstruction of a criminal investigation involving healthcare offenses.
Federal authorities alleged that Dr. Mailyan submitted claims for expensive Botox injections that were either not medically necessary, not provided as billed, or supported by falsified medical documentation. Many of the claims reportedly involved neurological conditions that typically qualify for Medicare reimbursement, including chronic migraines, muscle spasms, and other neurological disorders.
According to court documents, Medicare generally covers Botox injections only when medically necessary and supported by documented diagnoses and physician referrals. Investigators alleged that many injections billed by Dr. Mailyan were cosmetic procedures or treatments that never occurred.
Prosecutors also alleged that fabricated chronic migraine diagnoses were frequently used to justify Medicare reimbursement claims. Authorities further alleged that some patients billed for Botox treatments had not been referred by primary care physicians for chronic migraine management, a requirement often needed for Medicare reimbursement.
The Department of Justice stated that the fraudulent claims totaled approximately $45 million.
Federal investigators also identified Dr. Violetta Mailyan as a top Medicare Botox reimbursement recipient, alleging that she received more Medicare Botox reimbursements than any other physician in the United States.
Prosecutors said she received more than $24 million in Medicare payments over four years, which was reportedly six times higher than the next highest group of providers, all of whom were neurologists.
According to prosecutors, the scheme relied on recruiters and unlawful referrals to bring Medicare beneficiaries into clinics connected to the operation.
Federal investigators alleged that patient records were manipulated to justify reimbursement claims and that some patients received medically unnecessary Botox treatments.
Authorities also accused those involved of using false diagnoses and fraudulent documentation to secure Medicare payments in what prosecutors described as a large-scale federal healthcare fraud and fraudulent medical billing scheme.
Trial evidence presented by prosecutors alleged that Dr. Violetta Mailyan billed Medicare for injections while she was traveling to locations including Cabo, Maui, Las Vegas, Pennsylvania, and New York.
Investigators also alleged that claims were submitted for treatments supposedly performed while the clinic was closed.
Court records further alleged that one Medicare beneficiary billed for Botox treatment was incarcerated in federal prison at the time the injection was supposedly administered.
Prosecutors also alleged that some medical records and consent forms were backdated or fabricated to support reimbursement claims and mislead investigators.
Authorities also alleged that altered and fabricated records were submitted in response to a federal grand jury subpoena during the investigation.
The case was investigated by several federal agencies, including the FBI and the US Department of Health and Human Services Office of Inspector General (HHS-OIG).
Federal investigators used Medicare billing data to compare Botox reimbursement patterns among physicians nationwide. Authorities alleged that Dr. Violetta Mailyan’s billing volume and reimbursement amounts far exceeded typical neurology practices, prompting further investigation into possible healthcare fraud.
Federal officials said the investigation demonstrated how data analytics are increasingly used to identify suspicious Medicare billing patterns.
Although Botox is widely associated with cosmetic procedures, the drug also has several approved medical uses.
Doctors use botulinum toxin injections to treat conditions such as chronic migraines, muscle stiffness, cervical dystonia, excessive sweating, and certain neurological disorders. Because these treatments often involve repeated injections and high reimbursement costs, Medicare billing for Botox is closely monitored.
Federal investigators said false billing schemes involving injectable therapies can place patients at risk while increasing financial pressure on public healthcare programs.
According to authorities, many patients involved in the California case were elderly Medicare beneficiaries.
Chronic migraines are among the most common medically approved indications for Botox reimbursement under Medicare guidelines.
Prosecutors alleged that fabricated chronic migraine diagnoses were frequently used to justify Medicare reimbursement claims. Authorities also alleged that some patients billed for Botox treatments lacked appropriate physician referrals typically required for Medicare coverage.
Federal authorities alleged that many Botox claims submitted in the case involved neurological conditions commonly used to qualify for Medicare reimbursement, including chronic migraines and muscle spasms.
Officials said the case also raised concerns about patient safety, not just financial fraud.
Medically unnecessary Botox treatments may expose patients to avoidable side effects, complications, anxiety, and additional healthcare expenses. In rare cases, improper Botox administration can lead to swallowing difficulties, breathing problems, or muscle weakness.
Federal officials said healthcare fraud remains a major enforcement priority because fraudulent billing practices, Medicare scams, and Botox reimbursement fraud can divert public healthcare funds away from patients who genuinely need medical care.
Dr. Violetta Mailyan is expected to face sentencing in federal court on September 10, 2026. According to the Department of Justice, convictions linked to large-scale healthcare fraud schemes can result in substantial prison sentences and financial penalties.
Federal prosecutors said Dr. Mailyan faces a maximum sentence of 20 years in prison for each wire fraud count and up to five years for each obstruction count.
Authorities stated that prosecutors are seeking forfeiture of several assets allegedly linked to the fraud scheme, including luxury vehicles, brokerage accounts, bank funds, and California real estate holdings. Court records and media reports also identified assets allegedly connected to the case, including a Tesla Cybertruck, a 17th-century antique crossbow reportedly valued at nearly $12,000, luxury vacations, and multiple California properties.
Federal prosecutors said the case reflects broader efforts to crack down on Medicare fraud and abuse across the healthcare system.
1. U.S. Department of Justice. “California Doctor Convicted of $45M Botox Fraud Scheme Targeting Medicare.” Office of Public Affairs. May 19, 2026. Accessed May 23, 2026. U.S. Department of Justice.
(Rh/TP/MSM)
